Jinling Pharmaceutical Company Limited (SHE:000919)
China flag China · Delayed Price · Currency is CNY
6.50
+0.07 (1.09%)
Sep 30, 2026, 3:04 PM CST

SHE:000919 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,4171,5171,7711,5481,4951,502
Short-Term Investments
268.54393.03165.22337.45250-
Trading Asset Securities
1,223939.31706.05233.8692.351.25
Cash & Short-Term Investments
2,9082,8492,6422,1191,8371,503
Cash Growth
9.14%7.84%24.69%15.33%22.25%14.12%
Accounts Receivable
592.25690.95686.73591.05467.22507.2
Other Receivables
14.8813.798.168.7653.1216.85
Receivables
607.12704.74694.89599.81520.34524.05
Inventory
202.3233.14271.62290.91250.48245.48
Prepaid Expenses
---0.151.16-
Other Current Assets
12.6110.529.379.6323.7916.29
Total Current Assets
3,7303,7983,6183,0202,6332,289
Property, Plant & Equipment
1,4341,4571,5011,5411,3031,297
Long-Term Investments
300.13211.37431.07369.32265.01638.97
Goodwill
44.3744.3762.42148.7227.3318.05
Other Intangible Assets
310.63322.93325.67341.67258.44140.2
Long-Term Deferred Tax Assets
11.2312.6112.4916.6128.5419.62
Long-Term Deferred Charges
114.32120.5583.3413.9418.2617.85
Other Long-Term Assets
47.4740.3154.494210.726.96
Total Assets
5,9926,0076,0895,4934,5444,448

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
538.96554.97595.31546.69454.04479.36
Accrued Expenses
221.53222.28212.46224.73219.95207.27
Short-Term Debt
----1.4815.01
Current Portion of Leases
8.748.744.233.081.531.06
Current Income Taxes Payable
32.5532.3735.5337.9748.3843.09
Current Unearned Revenue
23.1819.5735.617.6522.1426.9
Other Current Liabilities
142.14138.03143.9182.53117.983.25
Total Current Liabilities
967.1975.951,0271,013865.42855.95
Long-Term Debt
150.09150.1150.12---
Long-Term Leases
33.232.9834.8538.62.290.59
Long-Term Unearned Revenue
3.460.6810.470.630.79
Long-Term Deferred Tax Liabilities
22.725.0127.2828.7248.9855.77
Total Liabilities
1,1771,1851,2401,080917.32913.1

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
621.92621.92623.71511.14510.4504
Additional Paid-In Capital
1,0881,0881,098651.74478.34462.06
Retained Earnings
2,0532,0652,0732,0952,0251,958
Treasury Stock
---6.77-26.99-23.62-
Comprehensive Income & Other
2.642.663.093.424.173.29
Total Common Equity
3,7663,7783,7913,2342,9942,928
Minority Interest
1,0501,0441,0571,178632.88606.84
Shareholders' Equity
4,8164,8224,8494,4123,6273,535
Total Liabilities & Equity
5,9926,0076,0895,4934,5444,448

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
192.02191.82189.2141.675.316.66
Net Cash (Debt)
2,7162,6582,4532,0771,8321,486
Net Cash Growth
9.75%8.34%18.08%13.39%23.26%12.85%
Net Cash Per Share
4.374.274.144.123.642.95
Filing Date Shares Outstanding
621.92621.92623.71629.06488.88510.4
Total Common Shares Outstanding
621.92621.92623.71511.14488.88504
Working Capital
2,7632,8222,5912,0071,7681,433
Book Value Per Share
6.066.076.086.336.125.81
Tangible Book Value
3,4113,4103,4032,7442,7082,769
Tangible Book Value Per Share
5.485.485.465.375.545.50
Buildings
1,5021,5101,4951,5071,2941,274
Machinery
1,5211,4981,4161,3491,1141,074
Construction In Progress
72.3448.1671.7884.237.8428.78